Literature DB >> 4290464

Increased susceptibility of Down's syndrome fibroblasts to transformation by SV40.

G J Todaro, G M Martin.   

Abstract

Entities:  

Mesh:

Year:  1967        PMID: 4290464     DOI: 10.3181/00379727-124-31974

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  28 in total

1.  Malignancies in Down syndrome.

Authors:  P Kusumakumary; T S Vats; R Ankathil; H R Gattamaneni; M K Nair
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

2.  T-antigen expression in human skin fibroblasts is not regulated by an endogenous interferon response to SV40 infection.

Authors:  A S Lubiniecki; W A Blattner; V Cruttenden; M Gunnell; G C Tarr; J F Fraumeni
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  Properties of cells transformed by DNA tumor viruses.

Authors:  J S Butel; M K Estes
Journal:  In Vitro       Date:  1975 May-Jun

4.  Chromosome fragility and susceptibility of Bloom's syndrome fibroblasts to SV40 transformation.

Authors:  M S Lin; O S Alfi
Journal:  Experientia       Date:  1980-03-15

Review 5.  Asbestos, Simian virus 40 and malignant mesothelioma.

Authors:  S C Stenton
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

6.  Immunological deficiency and the risk of cancer.

Authors: 
Journal:  Br Med J       Date:  1977-09-10

7.  Familial acute myeloid leukaemia with acquired Pelger-Huet anomaly and aneuploidy of C group.

Authors:  J Kaur; D Catovsky; H Valdimarsson; O Jensson; A S Spiers
Journal:  Br Med J       Date:  1972-11-11

8.  Carcinogenesis in vitro. II. Chemical transformation of diploid human cell cultures: A rare event.

Authors:  H J Igel; A E Freeman; J E Spiewak; K L Kleinfeld
Journal:  In Vitro       Date:  1975 May-Jun

9.  Viral susceptibility of skin fibroblasts from patients with Huntington disease.

Authors:  C A Miller; S Rasheed
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

10.  [Mutations induced in vitro by an alkylating agent (zitostop) in malignant diseases and in syndromes predisposing to malignancy].

Authors:  D Schuler; G Fekete; M Dobos
Journal:  Humangenetik       Date:  1972
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.